Mechanisms, Diagnosis and Treatment of Bone Metastases

Bone and bone marrow are among the most frequent metastatic sites of cancer. The occurrence of bone metastasis is frequently associated with a dismal disease outcome. The prevention and therapy of bone metastases is a priority in the treatment of cancer patients. However, current therapeutic options...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jozef Ban, Valerie Fock, Dave N. T. Aryee, Heinrich Kovar
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
EMT
Acceso en línea:https://doaj.org/article/c9d3c1ae1b94426d9995667a6f98b0c8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c9d3c1ae1b94426d9995667a6f98b0c8
record_format dspace
spelling oai:doaj.org-article:c9d3c1ae1b94426d9995667a6f98b0c82021-11-25T17:09:33ZMechanisms, Diagnosis and Treatment of Bone Metastases10.3390/cells101129442073-4409https://doaj.org/article/c9d3c1ae1b94426d9995667a6f98b0c82021-10-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/2944https://doaj.org/toc/2073-4409Bone and bone marrow are among the most frequent metastatic sites of cancer. The occurrence of bone metastasis is frequently associated with a dismal disease outcome. The prevention and therapy of bone metastases is a priority in the treatment of cancer patients. However, current therapeutic options for patients with bone metastatic disease are limited in efficacy and associated with increased morbidity. Therefore, most current therapies are mainly palliative in nature. A better understanding of the underlying molecular pathways of the bone metastatic process is warranted to develop novel, well-tolerated and more successful treatments for a significant improvement of patients’ quality of life and disease outcome. In this review, we provide comparative mechanistic insights into the bone metastatic process of various solid tumors, including pediatric cancers. We also highlight current and innovative approaches to biologically targeted therapy and immunotherapy. In particular, we discuss the role of the bone marrow microenvironment in the attraction, homing, dormancy and outgrowth of metastatic tumor cells and the ensuing therapeutic implications. Multiple signaling pathways have been described to contribute to metastatic spread to the bone of specific cancer entities, with most knowledge derived from the study of breast and prostate cancer. However, it is likely that similar mechanisms are involved in different types of cancer, including multiple myeloma, primary bone sarcomas and neuroblastoma. The metastatic rate-limiting interaction of tumor cells with the various cellular and noncellular components of the bone-marrow niche provides attractive therapeutic targets, which are already partially exploited by novel promising immunotherapies.Jozef BanValerie FockDave N. T. AryeeHeinrich KovarMDPI AGarticlebone metastasismetastatic nichetumor microenvironment interactionsbone colonizationEMTmetastatic dormancyBiology (General)QH301-705.5ENCells, Vol 10, Iss 2944, p 2944 (2021)
institution DOAJ
collection DOAJ
language EN
topic bone metastasis
metastatic niche
tumor microenvironment interactions
bone colonization
EMT
metastatic dormancy
Biology (General)
QH301-705.5
spellingShingle bone metastasis
metastatic niche
tumor microenvironment interactions
bone colonization
EMT
metastatic dormancy
Biology (General)
QH301-705.5
Jozef Ban
Valerie Fock
Dave N. T. Aryee
Heinrich Kovar
Mechanisms, Diagnosis and Treatment of Bone Metastases
description Bone and bone marrow are among the most frequent metastatic sites of cancer. The occurrence of bone metastasis is frequently associated with a dismal disease outcome. The prevention and therapy of bone metastases is a priority in the treatment of cancer patients. However, current therapeutic options for patients with bone metastatic disease are limited in efficacy and associated with increased morbidity. Therefore, most current therapies are mainly palliative in nature. A better understanding of the underlying molecular pathways of the bone metastatic process is warranted to develop novel, well-tolerated and more successful treatments for a significant improvement of patients’ quality of life and disease outcome. In this review, we provide comparative mechanistic insights into the bone metastatic process of various solid tumors, including pediatric cancers. We also highlight current and innovative approaches to biologically targeted therapy and immunotherapy. In particular, we discuss the role of the bone marrow microenvironment in the attraction, homing, dormancy and outgrowth of metastatic tumor cells and the ensuing therapeutic implications. Multiple signaling pathways have been described to contribute to metastatic spread to the bone of specific cancer entities, with most knowledge derived from the study of breast and prostate cancer. However, it is likely that similar mechanisms are involved in different types of cancer, including multiple myeloma, primary bone sarcomas and neuroblastoma. The metastatic rate-limiting interaction of tumor cells with the various cellular and noncellular components of the bone-marrow niche provides attractive therapeutic targets, which are already partially exploited by novel promising immunotherapies.
format article
author Jozef Ban
Valerie Fock
Dave N. T. Aryee
Heinrich Kovar
author_facet Jozef Ban
Valerie Fock
Dave N. T. Aryee
Heinrich Kovar
author_sort Jozef Ban
title Mechanisms, Diagnosis and Treatment of Bone Metastases
title_short Mechanisms, Diagnosis and Treatment of Bone Metastases
title_full Mechanisms, Diagnosis and Treatment of Bone Metastases
title_fullStr Mechanisms, Diagnosis and Treatment of Bone Metastases
title_full_unstemmed Mechanisms, Diagnosis and Treatment of Bone Metastases
title_sort mechanisms, diagnosis and treatment of bone metastases
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/c9d3c1ae1b94426d9995667a6f98b0c8
work_keys_str_mv AT jozefban mechanismsdiagnosisandtreatmentofbonemetastases
AT valeriefock mechanismsdiagnosisandtreatmentofbonemetastases
AT daventaryee mechanismsdiagnosisandtreatmentofbonemetastases
AT heinrichkovar mechanismsdiagnosisandtreatmentofbonemetastases
_version_ 1718412678212354048